XPH Holdings Information

XPH is an equity ETF with a total of 67 individual holdings. The top holdings are Crinetics Pharmaceuticals stock at 3.75%, MBX Biosciences at 2.98%, Definium Therapeutics at 2.89%, Alumis at 2.15%, and Enliven Therapeutics at 2.11%.

Total Holdings

Top 10 Percentage

23.65%

Asset Class

Equity

ETF Category

Health

Assets

342.67M

PE Ratio

14.96

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	CRNX	Crinetics Pharmaceuticals, Inc.	3.75%	206,819
2	MBX	MBX Biosciences, Inc.	2.98%	229,042
3	DFTX	Definium Therapeutics, Inc.	2.89%	305,423
4	ALMS	Alumis Inc.	2.15%	353,840
5	ELVN	Enliven Therapeutics, Inc.	2.11%	191,839
6	ATAI	AtaiBeckley Inc.	2.02%	1,877,785
7	AMLX	Amylyx Pharmaceuticals, Inc.	1.99%	527,342
8	NUVB	Nuvation Bio Inc.	1.94%	1,549,787
9	EWTX	Edgewise Therapeutics, Inc.	1.93%	215,614
10	LGND	Ligand Pharmaceuticals Incorporated	1.91%	28,593
11	TRVI	Trevi Therapeutics, Inc.	1.89%	529,703
12	NKTR	Nektar Therapeutics	1.85%	125,009
13	MAZE	Maze Therapeutics, Inc.	1.82%	288,607
14	MANE	Veradermics, Incorporated	1.82%	76,339
15	HROW	Harrow, Inc.	1.79%	197,717
16	EYPT	EyePoint, Inc.	1.78%	575,671
17	OCUL	Ocular Therapeutix, Inc.	1.74%	812,131
18	AMRX	Amneal Pharmaceuticals, Inc.	1.72%	463,318
19	CORT	Corcept Therapeutics Incorporated	1.69%	90,861
20	ELAN	Elanco Animal Health Incorporated	1.69%	310,364
21	LQDA	Liquidia Corporation	1.68%	108,782
22	PCRX	Pacira BioSciences, Inc.	1.68%	303,075
23	JNJ	Johnson & Johnson	1.66%	29,762
24	BMY	Bristol-Myers Squibb Company	1.64%	127,662
25	INDV	Indivior Pharmaceuticals, Inc.	1.62%	186,349

Showing 25 of 67 holdings

Subscribe to see the full list

Activate Now

As of Jul 13, 2026